139 related articles for article (PubMed ID: 21398193)
1. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer.
Roth C; Kasimir-Bauer S; Pantel K; Schwarzenbach H
Mol Oncol; 2011 Jun; 5(3):281-91. PubMed ID: 21398193
[TBL] [Abstract][Full Text] [Related]
2. Circulating nucleic acids as biomarkers in breast cancer.
Schwarzenbach H
Breast Cancer Res; 2013; 15(5):211. PubMed ID: 24090167
[TBL] [Abstract][Full Text] [Related]
3. Genetic Markers in Lung Cancer Diagnosis: A Review.
Wadowska K; Bil-Lula I; Trembecki Ł; Śliwińska-Mossoń M
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32604993
[TBL] [Abstract][Full Text] [Related]
4. Circulating biomarkers to monitor cancer progression and treatment.
Rapisuwon S; Vietsch EE; Wellstein A
Comput Struct Biotechnol J; 2016; 14():211-22. PubMed ID: 27358717
[TBL] [Abstract][Full Text] [Related]
5. Circulating Tumor Nucleic Acids: Perspective in Breast Cancer.
Casciano I; Vinci AD; Banelli B; Brigati C; Forlani A; Allemanni G; Romani M
Breast Care (Basel); 2010; 5(2):75-80. PubMed ID: 20847818
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Nucleic Acids in Urine: Sources, Structure, Diagnostic Potential.
Bryzgunova OE; Laktionov PP
Acta Naturae; 2015; 7(3):48-54. PubMed ID: 26483959
[TBL] [Abstract][Full Text] [Related]
7. Characterization of extracellular circulating microRNA.
Turchinovich A; Weiz L; Langheinz A; Burwinkel B
Nucleic Acids Res; 2011 Sep; 39(16):7223-33. PubMed ID: 21609964
[TBL] [Abstract][Full Text] [Related]
8. Non-Coding RNAs as Key Regulators in Lung Cancer.
Gilyazova I; Gimalova G; Nizamova A; Galimova E; Ishbulatova E; Pavlov V; Khusnutdinova E
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203731
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide variants in microRNA biosynthesis genes in Mexican individuals.
Juárez-Luis J; Canseco-Ocaña M; Cid-Soto MA; Castro-Martínez XH; Martínez-Hernández A; Orozco L; Hernández-Zavala A; Córdova EJ
Front Genet; 2023; 14():1022912. PubMed ID: 36968598
[No Abstract] [Full Text] [Related]
10. Contributions of Circulating microRNAs for Early Detection of Lung Cancer.
Vykoukal J; Fahrmann JF; Patel N; Shimizu M; Ostrin EJ; Dennison JB; Ivan C; Goodman GE; Thornquist MD; Barnett MJ; Feng Z; Calin GA; Hanash SM
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077759
[TBL] [Abstract][Full Text] [Related]
11. Methods for Collection of Extracellular Vesicles and Their Content RNA as Liquid Biopsy for Lung Cancer Detection: Application of Differential Centrifugation and Annexin A5 Coated Beads.
Wang MC; Gong GY; Wang CL; Ko HW; Weng RX; Chang PY; Chiou CC
Curr Issues Mol Biol; 2022 May; 44(5):2374-2386. PubMed ID: 35678691
[TBL] [Abstract][Full Text] [Related]
12. Precision Oncology: Artificial Intelligence and DNA Methylation Analysis of Circulating Cell-Free DNA for Lung Cancer Detection.
Bahado-Singh R; Vlachos KT; Aydas B; Gordevicius J; Radhakrishna U; Vishweswaraiah S
Front Oncol; 2022; 12():790645. PubMed ID: 35600397
[TBL] [Abstract][Full Text] [Related]
13. Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer.
Powrózek T; Ochieng Otieno M
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159070
[TBL] [Abstract][Full Text] [Related]
14. The application of artificial intelligence in lung cancer: a narrative review.
Zhang H; Meng D; Cai S; Guo H; Chen P; Zheng Z; Zhu J; Zhao W; Wang H; Zhao S; Yu J; He Y
Transl Cancer Res; 2021 May; 10(5):2478-2487. PubMed ID: 35116562
[TBL] [Abstract][Full Text] [Related]
15. Atomistic molecular dynamics simulations of tubulin heterodimers explain the motion of a microtubule.
Nasedkin A; Ermilova I; Swenson J
Eur Biophys J; 2021 Oct; 50(7):927-940. PubMed ID: 34215900
[TBL] [Abstract][Full Text] [Related]
16. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.
Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662
[TBL] [Abstract][Full Text] [Related]
17. Circulating MiR-10b, MiR-1 and MiR-30a Expression Profiles in Lung Cancer: Possible Correlation with Clinico-pathologic Characteristics and Lung Cancer Detection.
Sheervalilou R; Lotfi H; Shirvaliloo M; Sharifi A; Nazemiyeh M; Zarghami N
Int J Mol Cell Med; 2019; 8(2):118-129. PubMed ID: 32215263
[TBL] [Abstract][Full Text] [Related]
18. The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.
Shao C; Yang F; Qin Z; Jing X; Shu Y; Shen H
BMC Cancer; 2019 Nov; 19(1):1103. PubMed ID: 31727002
[TBL] [Abstract][Full Text] [Related]
19. Liquid Biopsy for the Detection of Resistance Mechanisms in NSCLC: Comparison of Different Blood Biomarkers.
Pasini L; Ulivi P
J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31323990
[TBL] [Abstract][Full Text] [Related]
20. Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies.
Madurantakam Royam M; Kumarasamy C; Baxi S; Gupta A; Ramesh N; Kodiveri Muthukaliannan G; Jayaraj R
Mol Diagn Ther; 2019 Feb; 23(1):65-82. PubMed ID: 30726546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
